Role of Micronutrients and Nutrition in Prevention and Treatment of Cancers
Keywords:
Micronutrients , Nutrition , Prevention , Treatment , CancersAbstract
Cancer is a complex disease that affects millions of people worldwide. While genetics and lifestyle factors play a significant role in cancer development, the role of diet and micronutrients in preventing and treating cancer is becoming increasingly apparent. Micronutrients, also known as vitamins and minerals, are essential for the proper function of the body's cells and play an important role in the immune system. Studies have shown that diets rich in fruits, vegetables, nuts, and whole grains are associated with a lower risk of various types of cancer. This is partly because these foods contain a variety of micronutrients, such as vitamin C, vitamin E, folate, selenium, and zinc, that have antioxidant and anti-inflammatory properties. Antioxidants are compounds that protect cells from damage caused by free radicals, which can contribute to cancer development. Micronutrients such as vitamin C, vitamin E, and selenium act as antioxidants in the body and can help reduce the risk of cancer. In addition, some studies suggest that folate may reduce the risk of colon cancer, while zinc may play a role in preventing prostate cancer. However, it's important to note that not all micronutrients are beneficial for cancer prevention. For example, high doses of beta-carotene supplements may increase the risk of lung cancer in smokers. Therefore, it's best to get micronutrients through a balanced diet rather than supplements. In addition to preventing cancer, a healthy diet rich in micronutrients can also help in cancer treatment. People undergoing cancer treatment often experience side effects such as fatigue, loss of appetite, and weight loss, which can be addressed by ensuring adequate intake of nutrients. In conclusion, the role of micronutrients and diet in cancer prevention and treatment cannot be understated. A diet rich in fruits, vegetables, nuts, and whole grains can help reduce the risk of cancer, while adequate intake of micronutrients such as vitamin C, vitamin E, folate, selenium, and zinc can provide additional protection. It's important to consult with a healthcare professional to ensure that dietary changes are appropriate for individual needs and medical conditions.
References
Alcantara EN, Speckmann EW. Diet, nutrition, and cancer. Am J Clin Nutr. 1976;29(9):1035-47.
Bao ZH, Hou XB, Li HL, Mao YF, Wang WR. The mechanism and progress of ferroptosis in pancreatic cancer. Acta Histochem. 2022;124(6):151919.
Barrea L, Gallo M, Ruggeri RM, Giacinto PD, Sesti F, Prinzi N, et al. Nutritional status and follicular-derived thyroid cancer: An update. Crit Rev Food Sci Nutr. 2021;61(1):25-59.
Barreto SG, Neale RE. Vitamin D and pancreatic cancer. Cancer Lett. 2015;368(1):1-6.
Bikle DD. Vitamin D and cancer: the promise not yet fulfilled. Endocrine. 2014;46(1):29-38.
Bizzarri M, Dinicola S, Cucina A. Modulation of both Insulin Resistance and Cancer Growth by Inositol. Curr Pharm Des. 2017;23(34):5200-10.
Chen J, Jiang W, Shao L, Zhong D, Wu Y, Cai J. Association between intake of antioxidants and pancreatic cancer risk: a meta-analysis. Int J Food Sci Nutr. 2016;67(7):744-53.
De Almeida R, McCalmon S, Cabandugama PK. Clinical Review and Update on the Management of Thyroid Storm. Mo Med. 2022;119(4):366-71.
De Dosso S, Siebenhüner AR, Winder T, Meisel A, Fritsch R, Astaras C, et al. Treatment landscape of metastatic pancreatic cancer. Cancer Treat Rev. 2021;96:102180.
De la Vieja A, Santisteban P. Role of iodide metabolism in physiology and cancer. Endocr Relat Cancer. 2018;25(4):R225-r45.
Draper A. Updates in pancreatic cancer: Modest gains and hopeful targets. J Oncol Pharm Pract. 2019;25(1):101-9.
Fallahi P, Ferrari SM, Santini F, Corrado A, Materazzi G, Ulisse S, et al. Sorafenib and thyroid cancer. BioDrugs. 2013;27(6):615-28.
Feldt-Rasmussen U. Iodine and cancer. Thyroid. 2001;11(5):483-6.
Giustina A, Bouillon R, Dawson-Hughes B, Ebeling PR, Lazaretti-Castro M, Lips P, et al. Vitamin D in the older population: a consensus statement. Endocrine. 2023;79(1):31-44.
Goyer RA, Liu J, Waalkes MP. Cadmium and cancer of prostate and testis. Biometals. 2004;17(5):555-8.
Hoang BX, Han B, Shaw DG, Nimni M. Zinc as a possible preventive and therapeutic agent in pancreatic, prostate, and breast cancer. Eur J Cancer Prev. 2016;25(5):457-61.
Holt EH. Current Evaluation of Thyroid Nodules. Med Clin North Am. 2021;105(6):1017-31.
Iglesias P, Díez JJ. Endocrine Complications of Surgical Treatment of Thyroid Cancer: An Update. Exp Clin Endocrinol Diabetes. 2017;125(8):497-505.
Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388(10039):73-85.
Kim D. The Role of Vitamin D in Thyroid Diseases. Int J Mol Sci. 2017;18(9).
Kipp AP. Selenium in colorectal and differentiated thyroid cancer. Hormones (Athens). 2020;19(1):41-6.
Knezevic J, Starchl C, Tmava Berisha A, Amrein K. Thyroid-Gut-Axis: How Does the Microbiota Influence Thyroid Function? Nutrients. 2020;12(6).
L'Espérance K, Datta GD, Qureshi S, Koushik A. Vitamin D Exposure and Ovarian Cancer Risk and Prognosis. Int J Environ Res Public Health. 2020;17(4).
Lawler T, Warren Andersen S. Serum 25-Hydroxyvitamin D and Cancer Risk: A Systematic Review of Mendelian Randomization Studies. Nutrients. 2023;15(2).
Leyssens L, Vinck B, Van Der Straeten C, Wuyts F, Maes L. Cobalt toxicity in humans-A review of the potential sources and systemic health effects. Toxicology. 2017;387:43-56.
Lin HL, An QZ, Wang QZ, Liu CX. Folate intake and pancreatic cancer risk: an overall and dose-response meta-analysis. Public Health. 2013;127(7):607-13.
Ma Y, Trump DL, Johnson CS. Vitamin D and miRNAs in cancer. Curr Gene Ther. 2014;14(4):269-75.
Maciejewski A, Lacka K. Vitamin D-Related Genes and Thyroid Cancer-A Systematic Review. Int J Mol Sci. 2022;23(21).
Meerza D, Naseem I, Ahmad J. Diabetes, pancreatic cancer and vitamin D. Is there a link? Diabetes Metab Syndr. 2011;5(4):218-21.
Mijovic T, How J, Payne RJ. Obesity and thyroid cancer. Front Biosci (Schol Ed). 2011;3(2):555-64.
Milano G, Innocenti F, Minami H. Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs. Cancer Sci. 2022;113(7):2224-31.
Mondul AM, Weinstein SJ, Layne TM, Albanes D. Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges. Epidemiol Rev. 2017;39(1):28-48.
Murdolo G, Bartolini D, Tortoioli C, Piroddi M, Torquato P, Galli F. Selenium and Cancer Stem Cells. Adv Cancer Res. 2017;136:235-57.
Nishimoto A. Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment. World J Gastroenterol. 2022;28(28):3637-43.
Piatek K, Schepelmann M, Kallay E. The Effect of Vitamin D and Its Analogs in Ovarian Cancer. Nutrients. 2022;14(18).
Poulia KA, Sarantis P, Antoniadou D, Koustas E, Papadimitropoulou A, Papavassiliou AG, et al. Pancreatic Cancer and Cachexia-Metabolic Mechanisms and Novel Insights. Nutrients. 2020;12(6).
Rua RM, Nogales F, Carreras O, Ojeda ML. Selenium, selenoproteins and cancer of the thyroid. J Trace Elem Med Biol. 2023;76:127115.
Sarvepalli D, Rashid MU, Rahman AU, Ullah W, Hussain I, Hasan B, et al. Gemcitabine: A Review of Chemoresistance in Pancreatic Cancer. Crit Rev Oncog. 2019;24(2):199-212.
Scaranti M, Cojocaru E, Banerjee S, Banerji U. Exploiting the folate receptor α in oncology. Nat Rev Clin Oncol. 2020;17(6):349-59.
Stolzenberg-Solomon RZ. Vitamin D and pancreatic cancer. Ann Epidemiol. 2009;19(2):89-95.
Suker M, Beumer BR, Sadot E, Marthey L, Faris JE, Mellon EA, et al. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol. 2016;17(6):801-10.
Welsh J. Function of the vitamin D endocrine system in mammary gland and breast cancer. Mol Cell Endocrinol. 2017;453:88-95.
White PT, Cohen MS. The discovery and development of sorafenib for the treatment of thyroid cancer. Expert Opin Drug Discov. 2015;10(4):427-39.
Yang F, Jin C, Fu DL, Warshaw AL. Modified FOLFIRINOX for resected pancreatic cancer: Opportunities and challenges. World J Gastroenterol. 2019;25(23):2839-45.
Yildirim Simsir I, Cetinkalp S, Kabalak T. Review of Factors Contributing to Nodular Goiter and Thyroid Carcinoma. Med Princ Pract. 2020;29(1):1-5.
Zhang B, Zhou F, Hong J, Ng DM, Yang T, Zhou X, et al. The role of FOLFIRINOX in metastatic pancreatic cancer: a meta-analysis. World J Surg Oncol. 2021;19(1):182.
Zhang LR, Sawka AM, Adams L, Hatfield N, Hung RJ. Vitamin and mineral supplements and thyroid cancer: a systematic review. Eur J Cancer Prev. 2013;22(2):158-68.
Zheng J, Guinter MA, Merchant AT, Wirth MD, Zhang J, Stolzenberg-Solomon RZ, et al. Dietary patterns and risk of pancreatic cancer: a systematic review. Nutr Rev. 2017;75(11):883-908.
Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3(4):286-95.
Abnet CC, Arnold M, Wei WQ. Epidemiology of Esophageal Squamous Cell Carcinoma. Gastroenterology. 2018;154(2):360-73.
Amieva M, Peek RM, Jr. Pathobiology of Helicobacter pylori-Induced Gastric Cancer. Gastroenterology. 2016;150(1):64-78.
Battistini C, Ballan R, Herkenhoff ME, Saad SMI, Sun J. Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases. Int J Mol Sci. 2020;22(1).
Bouri S, Martin J. Investigation of iron deficiency anaemia Clin Med (Lond). 2018;18(3):242-4.
Esposito G, Dottori L, Pivetta G, Ligato I, Dilaghi E, Lahner E. Pernicious Anemia: The Hematological Presentation of a Multifaceted Disorder Caused by Cobalamin Deficiency. Nutrients. 2022;14(8).
Eusebi LH, Rabitti S, Artesiani ML, Gelli D, Montagnani M, Zagari RM, et al. Proton pump inhibitors: Risks of long-term use. J Gastroenterol Hepatol. 2017;32(7):1295-302.
Freedberg DE, Kim LS, Yang YX. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology. 2017;152(4):706-15.
Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am. 2002;31(4):925-43.
Giunta EF, Bregni G, Pretta A, Deleporte A, Liberale G, Bali AM, et al. Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials. Cancer Treat Rev. 2021;96:102177.
Inglis JE, Lin PJ, Kerns SL, Kleckner IR, Kleckner AS, Castillo DA, et al. Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review. Nutr Cancer. 2019;71(1):21-40.
Katona BW, Weiss JM. Chemoprevention of Colorectal Cancer. Gastroenterology. 2020;158(2):368-88.
Khan A, Vege SS, Dudeja V, Chari ST. Staging exocrine pancreatic dysfunction. Pancreatology. 2022;22(1):168-72.
Kim H, Giovannucci E. Vitamin D Status and Cancer Incidence, Survival, and Mortality. Adv Exp Med Biol. 2020;1268:39-52.
Lampe JW. Dairy products and cancer. J Am Coll Nutr. 2011;30(5 Suppl 1):464s-70s.
Meeker S, Seamons A, Maggio-Price L, Paik J. Protective links between vitamin D, inflammatory bowel disease and colon cancer. World J Gastroenterol. 2016;22(3):933-48.
Peterson CT, Rodionov DA, Osterman AL, Peterson SN. B Vitamins and Their Role in Immune Regulation and Cancer. Nutrients. 2020;12(11).
Phipps O, Brookes MJ, Al-Hassi HO. Iron deficiency, immunology, and colorectal cancer. Nutr Rev. 2021;79(1):88-97.
Snaidr VA, Damian DL, Halliday GM. Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety. Exp Dermatol. 2019;28 Suppl 1:15-22.
Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015;148(6):1244-60.e16.
Stein J, Connor S, Virgin G, Ong DE, Pereyra L. Anemia and iron deficiency in gastrointestinal and liver conditions. World J Gastroenterol. 2016;22(35):7908-25.
Thakur K, Tomar SK, Singh AK, Mandal S, Arora S. Riboflavin and health: A review of recent human research. Crit Rev Food Sci Nutr. 2017;57(17):3650-60.
Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010-21.
Vernia F, Longo S, Stefanelli G, Viscido A, Latella G. Dietary Factors Modulating Colorectal Carcinogenesis. Nutrients. 2021;13(1).
Wang Y, Zhang Z, Sun W, Zhang J, Xu Q, Zhou X, et al. Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets. Biomed Pharmacother. 2022;153:113524.
Xu C, Liu Z, Xiao J. Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease. Int J Mol Sci. 2021;22(22).
Yang X, Tang Z, Li J, Jiang J. Esophagus cancer and essential trace elements. Front Public Health. 2022;10:1038153.
Abiri B, Vafa M. Iron Deficiency and Anemia in Cancer Patients: The Role of Iron Treatment in Anemic Cancer Patients. Nutr Cancer. 2020;72(5):864-72.
Asonitis N, Angelousi A, Zafeiris C, Lambrou GI, Dontas I, Kassi E. Diagnosis, Pathophysiology and Management of Hypercalcemia in Malignancy: A Review of the Literature. Horm Metab Res. 2019;51(12):770-8.
Beck JJ, Mahan ST, Nowicki P, Schreiber VM, Minkowitz B. What Is New in Pediatric Bone Health. J Pediatr Orthop. 2021;41(8):e594-e9.
Cohen JE, Wakefield CE, Cohn RJ. Nutritional interventions for survivors of childhood cancer. Cochrane Database Syst Rev. 2016;2016(8):Cd009678.
Cunningham-Rundles S, Kim SH, Dnistrian A, Noroski L, Menendez-Botet C, Grassey CB, et al. Micronutrient and cytokine interaction in congenital pediatric HIV infection. J Nutr. 1996;126(10 Suppl):2674s-9s.
Deeks ED. Asciminib: First Approval. Drugs. 2022;82(2):219-26.
DeLoughery TG. Microcytic anemia. N Engl J Med. 2014;371(14):1324-31.
Deng Y, Wang L, Huang J, Ding H, Wong MCS. Associations between potential causal factors and colorectal cancer risk: A systematic review and meta-analysis of Mendelian randomization studies. J Dig Dis. 2022;23(8-9):435-45.
Diorio C, Kelly KM, Afungchwi GM, Ladas EJ, Marjerrison S. Nutritional traditional and complementary medicine strategies in pediatric cancer: A narrative review. Pediatr Blood Cancer. 2020;67 Suppl 3:e28324.
Facchinetti F, Unfer V, Dewailly D, Kamenov ZA, Diamanti-Kandarakis E, Laganà AS, et al. Inositols in Polycystic Ovary Syndrome: An Overview on the Advances. Trends Endocrinol Metab. 2020;31(6):435-47.
Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14(5):342-57.
García-Montero C, Fraile-Martínez O, Gómez-Lahoz AM, Pekarek L, Castellanos AJ, Noguerales-Fraguas F, et al. Nutritional Components in Western Diet Versus Mediterranean Diet at the Gut Microbiota-Immune System Interplay. Implications for Health and Disease. Nutrients. 2021;13(2).
Gattermann N, Muckenthaler MU, Kulozik AE, Metzgeroth G, Hastka J. The Evaluation of Iron Deficiency and Iron Overload. Dtsch Arztebl Int. 2021;118(49):847-56.
Horakova D, Bouchalova K, Cwiertka K, Stepanek L, Vlckova J, Kollarova H. Risks and protective factors for triple negative breast cancer with a focus on micronutrients and infections. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018;162(2):83-9.
Issaq SH, Heske CM. Targeting metabolic dependencies in pediatric cancer. Curr Opin Pediatr. 2020;32(1):26-34.
Kim TY, Kim S, Schafer AL. Medical Management of the Postoperative Bariatric Surgery Patient. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc. Copyright © 2000-2023, MDText.com, Inc.; 2000.
Lin Z, Liu J, Kang R, Yang M, Tang D. Lipid Metabolism in Ferroptosis. Adv Biol (Weinh). 2021;5(8):e2100396.
Motlaghzadeh Y, Bilezikian JP, Sellmeyer DE. Rare Causes of Hypercalcemia: 2021 Update. J Clin Endocrinol Metab. 2021;106(11):3113-28.
Muckenthaler MU, Rivella S, Hentze MW, Galy B. A Red Carpet for Iron Metabolism. Cell. 2017;168(3):344-61.
Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021;397(10270):233-48.
Pawlowska E, Szczepanska J, Blasiak J. Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations. Oxid Med Cell Longev. 2019;2019:7286737.
Revuelta Iniesta R, Rush R, Paciarotti I, Rhatigan EB, Brougham FHM, McKenzie JM, et al. Systematic review and meta-analysis: Prevalence and possible causes of vitamin D deficiency and insufficiency in pediatric cancer patients. Clin Nutr. 2016;35(1):95-108.
Schwingshackl L, Boeing H, Stelmach-Mardas M, Gottschald M, Dietrich S, Hoffmann G, et al. Dietary Supplements and Risk of Cause-Specific Death, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Analysis of Primary Prevention Trials. Adv Nutr. 2017;8(1):27-39.
Socha DS, DeSouza SI, Flagg A, Sekeres M, Rogers HJ. Severe megaloblastic anemia: Vitamin deficiency and other causes. Cleve Clin J Med. 2020;87(3):153-64.
Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 2017;171(2):273-85.
Walker VP, Modlin RL. The vitamin D connection to pediatric infections and immune function. Pediatr Res. 2009;65(5 Pt 2):106r-13r.
Widemann BC, Adamson PC. Understanding and managing methotrexate nephrotoxicity. Oncologist. 2006;11(6):694-703.
Xia X, Fan X, Zhao M, Zhu P. The Relationship between Ferroptosis and Tumors: A Novel Landscape for Therapeutic Approach. Curr Gene Ther. 2019;19(2):117-24.
Yiu TT, Li W. Pediatric cancer epigenome and the influence of folate. Epigenomics. 2015;7(6):961-73.
Akpunar D, Bebis H, Yavan T. Use of Complementary and Alternative Medicine in Patients with Gynecologic Cancer: a Systematic Review. Asian Pac J Cancer Prev. 2015;16(17):7847-52.
Attar R, Gasparri ML, Donato VD, Yaylim I, Halim TA, Zaman F, et al. Ovarian cancer: interplay of vitamin D signaling and miRNA action. Asian Pac J Cancer Prev. 2014;15(8):3359-62.
Bizzarri M, Fuso A, Dinicola S, Cucina A, Bevilacqua A. Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease. Expert Opin Drug Metab Toxicol. 2016;12(10):1181-96.
Ćwiertnia A, Kozłowski M, Cymbaluk-Płoska A. The Role of Iron and Cobalt in Gynecological Diseases. Cells. 2022;12(1).
de La Puente-Yagüe M, Cuadrado-Cenzual MA, Ciudad-Cabañas MJ, Hernández-Cabria M, Collado-Yurrita L. Vitamin D: And its role in breast cancer. Kaohsiung J Med Sci. 2018;34(8):423-7.
Deuster E, Jeschke U, Ye Y, Mahner S, Czogalla B. Vitamin D and VDR in Gynecological Cancers-A Systematic Review. Int J Mol Sci. 2017;18(11).
Di Tucci C, Di Feliciantonio M, Vena F, Capone C, Schiavi MC, Pietrangeli D, et al. Alpha lipoic acid in obstetrics and gynecology. Gynecol Endocrinol. 2018;34(9):729-33.
Grammatikopoulou MG, Gkiouras K, Papageorgiou S, Myrogiannis I, Mykoniatis I, Papamitsou T, et al. Dietary Factors and Supplements Influencing Prostate Specific-Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled Trials. Nutrients. 2020;12(10).
Guo H, Guo J, Xie W, Yuan L, Sheng X. The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention. J Ovarian Res. 2018;11(1):71.
Harper DM, Demars LR. Primary strategies for HPV infection and cervical cancer prevention. Clin Obstet Gynecol. 2014;57(2):256-78.
Harris HR, Orsini N, Wolk A. Vitamin C and survival among women with breast cancer: a meta-analysis. Eur J Cancer. 2014;50(7):1223-31.
Kajiyama H, Suzuki S, Yoshihara M, Tamauchi S, Yoshikawa N, Niimi K, et al. Endometriosis and cancer. Free Radic Biol Med. 2019;133:186-92.
Matsumoto K, Onda T, Yaegashi N. Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives. Jpn J Clin Oncol. 2015;45(5):408-10.
Michalczyk K, Cymbaluk-Płoska A. The Role of Zinc and Copper in Gynecological Malignancies. Nutrients. 2020;12(12).
Pérez-López FR, Chedraui P, Haya J. Review article: vitamin D acquisition and breast cancer risk. Reprod Sci. 2009;16(1):7-19.
Romney SL, Palan PR, Basu J, Mikhail M. Nutrient antioxidants in the pathogenesis and prevention of cervical dysplasias and cancer. J Cell Biochem Suppl. 1995;23:96-103.
Salvagno C, Mandula JK, Rodriguez PC, Cubillos-Ruiz JR. Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity. Trends Cancer. 2022;8(11):930-43.
Sun S, Cai J, Yang Q, Zhao S, Wang Z. The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets. Oncotarget. 2017;8(9):16036-51.
van den Brand D, Mertens V, Massuger L, Brock R. siRNA in ovarian cancer - Delivery strategies and targets for therapy. J Control Release. 2018;283:45-58.
Wang X, Fu S, Freedman RS, Kavanagh JJ. Venous thromboembolism syndrome in gynecological cancer. Int J Gynecol Cancer. 2006;16 Suppl 1:458-71.
Xu J, Chen K, Zhao F, Huang D, Zhang H, Fu Z, et al. Association between vitamin D/calcium intake and 25-hydroxyvitamin D and risk of ovarian cancer: a dose-response relationship meta-analysis. Eur J Clin Nutr. 2021;75(3):417-29.
Argiris A, Jayaram P, Pichardo D. Revisiting induction chemotherapy for head and neck cancer. Oncology (Williston Park). 2005;19(6):759-70.
Baker SR, Wheeler R. Intraarterial chemotherapy for head and neck cancer, Part 2: Clinical experience. Head Neck Surg. 1984;6(3):751-60.
Blahd WH, Rose JG. Nuclear medicine in diagnosis and treatment of diseases of the head and neck. I. Salivary and parathyroid gland disease and one identification and staging of head and neck tumors. Head Neck Surg. 1981;4(2):129-35.
Blaszczak W, Barczak W, Masternak J, Kopczyński P, Zhitkovich A, Rubiś B. Vitamin C as a Modulator of the Response to Cancer Therapy. Molecules. 2019;24(3).
Browman GP, Goodyear MD, Levine MN, Russell R, Archibald SD, Young JE. Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial. J Clin Oncol. 1990;8(2):203-8.
Cann CI, Fried MP, Rothman KJ. Epidemiology of squamous cell cancer of the head and neck. Otolaryngol Clin North Am. 1985;18(3):367-88.
Clarke R. Challenges threaten, opportunity awaits hyperbaric medicine and the head and neck cancer patient. Undersea Hyperb Med. 2019;46(4):385-97.
de Vries N, van Zandwijk N, Pastorino U. Chemoprevention of head and neck and lung (pre)cancer. Recent Results Cancer Res. 1999;151:13-25.
Fathi N, Ahmadian E, Shahi S, Roshangar L, Khan H, Kouhsoltani M, et al. Role of vitamin D and vitamin D receptor (VDR) in oral cancer. Biomed Pharmacother. 2019;109:391-401.
Galbiatti AL, Ruiz MT, Maniglia JV, Raposo LS, Pavarino-Bertelli EC, Goloni-Bertollo EM. Head and neck cancer: genetic polymorphisms and folate metabolism. Braz J Otorhinolaryngol. 2012;78(1):132-9.
Gao J, Panizza B, Johnson NW, Coman S, Clough AR. Basic consideration of research strategies for head and neck cancer. Front Med. 2012;6(4):339-53.
Harvie M. Nutritional supplements and cancer: potential benefits and proven harms. Am Soc Clin Oncol Educ Book. 2014:e478-86.
Hong WK, Bromer R. Chemotherapy in head and neck cancer. N Engl J Med. 1983;308(2):75-9.
Hsieh PL, Chao SC, Chu PM, Yu CC. Regulation of Ferroptosis by Non-Coding RNAs in Head and Neck Cancers. Int J Mol Sci. 2022;23(6).
Huber MH, Hong WK. Biology and chemoprevention of head and neck cancer. Curr Probl Cancer. 1994;18(2):81-140.
Izreig S, Hajek M, Edwards HA, Mehra S, Sasaki C, Judson BL, et al. The role of vitamin D in head and neck cancer. Laryngoscope Investig Otolaryngol. 2020;5(6):1079-88.
Jain A, Tiwari A, Verma A, Jain SK. Vitamins for Cancer Prevention and Treatment: An Insight. Curr Mol Med. 2017;17(5):321-40.
Kane MA. The role of folates in squamous cell carcinoma of the head and neck. Cancer Detect Prev. 2005;29(1):46-53.
Khlifi R, Hamza-Chaffai A. Head and neck cancer due to heavy metal exposure via tobacco smoking and professional exposure: a review. Toxicol Appl Pharmacol. 2010;248(2):71-88.
Khuri FR, Lippman SM, Spitz MR, Lotan R, Hong WK. Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J Natl Cancer Inst. 1997;89(3):199-211.
Kiremidjian-Schumacher L, Roy M. Effect of selenium on the immunocompetence of patients with head and neck cancer and on adoptive immunotherapy of early and established lesions. Biofactors. 2001;14(1-4):161-8.
Lee J, Roh JL. Induction of ferroptosis in head and neck cancer: A novel bridgehead for fighting cancer resilience. Cancer Lett. 2022;546:215854.
Lee J, Roh JL. Ferroptosis induction via targeting metabolic alterations in head and neck cancer. Crit Rev Oncol Hematol. 2023;181:103887.
Lee J, Roh JL. Altered iron metabolism as a target for ferroptosis induction in head and neck cancer. Cell Oncol (Dordr). 2023.
Lippman SM, Hawk ET. Cancer prevention: from 1727 to milestones of the past 100 years. Cancer Res. 2009;69(13):5269-84.
Mobarhan S. Micronutrient supplementation trials and the reduction of cancer and cerebrovascular incidence and mortality. Nutr Rev. 1994;52(3):102-5.
Niedzwiecki A, Roomi MW, Kalinovsky T, Rath M. Anticancer Efficacy of Polyphenols and Their Combinations. Nutrients. 2016;8(9).
Nikas IP, Paschou SA, Ryu HS. The Role of Nicotinamide in Cancer Chemoprevention and Therapy. Biomolecules. 2020;10(3).
Palladino-Davis AG, Mendez BM, Fisichella PM, Davis CS. Dietary habits and esophageal cancer. Dis Esophagus. 2015;28(1):59-67.
Posner MR, Colevas AD, Tishler RB. The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck. Semin Oncol. 2000;27(4 Suppl 8):13-24.
Prasad AS, Beck FW, Doerr TD, Shamsa FH, Penny HS, Marks SC, et al. Nutritional and zinc status of head and neck cancer patients: an interpretive review. J Am Coll Nutr. 1998;17(5):409-18.
Raza A, Karimyan N, Watters A, Emperumal CP, Al-Eryani K, Enciso R. Efficacy of oral and topical antioxidants in the prevention and management of oral mucositis in head and neck cancer patients: a systematic review and meta-analyses. Support Care Cancer. 2022;30(11):8689-703.
Ressnerova A, Raudenska M, Holubova M, Svobodova M, Polanska H, Babula P, et al. Zinc and Copper Homeostasis in Head and Neck Cancer: Review and Meta-Analysis. Curr Med Chem. 2016;23(13):1304-30.
Rice N, Polyzois I, Ekanayake K, Omer O, Stassen LF. The management of osteoradionecrosis of the jaws--a review. Surgeon. 2015;13(2):101-9.
Rivero JA, Shamji O, Kolokythas A. Osteoradionecrosis: a review of pathophysiology, prevention and pharmacologic management using pentoxifylline, α-tocopherol, and clodronate. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124(5):464-71.
Rodríguez-Molinero J, Migueláñez-Medrán BDC, Puente-Gutiérrez C, Delgado-Somolinos E, Martín Carreras-Presas C, Fernández-Farhall J, et al. Association between Oral Cancer and Diet: An Update. Nutrients. 2021;13(4).
Rosenthal DI, Trotti A. Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol. 2009;19(1):29-34.
Saba NF, Hammond A, Shin DM, Khuri FR. Moving toward bioadjuvant approaches to head and neck cancer prevention. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S132-5.
Seidman MD, Quirk WS, Shirwany NA. Reactive oxygen metabolites, antioxidants and head and neck cancer. Head Neck. 1999;21(5):467-79.
Shah GV, Fischbein NJ, Patel R, Mukherji SK. Newer MR imaging techniques for head and neck. Magn Reson Imaging Clin N Am. 2003;11(3):449-69, vi.
Sheth SH, Johnson DE, Kensler TW, Bauman JE. Chemoprevention targets for tobacco-related head and neck cancer: past lessons and future directions. Oral Oncol. 2015;51(6):557-64.
Smith BG, Lewin JS. Lymphedema management in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2010;18(3):153-8.
Sturgis EM. International Head and Neck Cancer Epidemiology Consortium: Update no. 12. Head Neck. 2013;35(10):1371-2.
Trizna Z, Schantz SP. Hereditary and environmental factors associated with risk and progression of head and neck cancer. Otolaryngol Clin North Am. 1992;25(5):1089-103.
Wennerberg J, Kjellén E, Lybak S, Rydell R, Pero R. Biochemical modulation of chemotherapy and radiotherapy in head and neck cancer. Anticancer Res. 1993;13(6b):2501-6.
Achebe MM, Gafter-Gvili A. How I treat anemia in pregnancy: iron, cobalamin, and folate. Blood. 2017;129(8):940-9.
Adams A, Scheckel B, Habsaoui A, Haque M, Kuhr K, Monsef I, et al. Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2022;6(6):Cd012633.
Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M. Oral Tranexamic Acid for the Treatment of Melasma: A Review. Dermatol Surg. 2018;44(6):814-25.
Bossaer JB, Covert KL. Direct oral anticoagulants in patients with cancer. Am J Health Syst Pharm. 2019;76(14):1019-27.
Botelho J, Machado V, Proença L, Delgado AS, Mendes JJ. Vitamin D Deficiency and Oral Health: A Comprehensive Review. Nutrients. 2020;12(5).
Chainani-Wu N. Diet and oral, pharyngeal, and esophageal cancer. Nutr Cancer. 2002;44(2):104-26.
Chen AC, Damian DL, Halliday GM. Oral and systemic photoprotection. Photodermatol Photoimmunol Photomed. 2014;30(2-3):102-11.
Chen X, Zou X, Qi G, Tang Y, Guo Y, Si J, et al. Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer. Cell Physiol Biochem. 2018;47(3):1060-73.
Coerdt KM, Goggins CA, Khachemoune A. Vitamins A, B, C, and D: A Short Review for the Dermatologist. Altern Ther Health Med. 2021;27(4):41-9.
DeLoughery TG. Iron Deficiency Anemia. Med Clin North Am. 2017;101(2):319-32.
Dickson K, Koom-Dadzie K, Brito-Dellan N, Escalante C. Risks, diagnosis, and management of recurrent cancer-associated thrombosis (CAT): a narrative review. Support Care Cancer. 2022;30(10):8539-45.
Elstrott B, Khan L, Olson S, Raghunathan V, DeLoughery T, Shatzel JJ. The role of iron repletion in adult iron deficiency anemia and other diseases. Eur J Haematol. 2020;104(3):153-61.
Fania L, Mazzanti C, Campione E, Candi E, Abeni D, Dellambra E. Role of Nicotinamide in Genomic Stability and Skin Cancer Chemoprevention. Int J Mol Sci. 2019;20(23).
Fitzpatrick T, Carrier M, Le Gal G. Cancer, atrial fibrillation, and stroke. Thromb Res. 2017;155:101-5.
Gafter-Gvili A, Schechter A, Rozen-Zvi B. Iron Deficiency Anemia in Chronic Kidney Disease. Acta Haematol. 2019;142(1):44-50.
Garavello W, Lucenteforte E, Bosetti C, La Vecchia C. The role of foods and nutrients on oral and pharyngeal cancer risk. Minerva Stomatol. 2009;58(1-2):25-34.
Garewal H. Chemoprevention of oral cancer: beta-carotene and vitamin E in leukoplakia. Eur J Cancer Prev. 1994;3(2):101-7.
Garrido-Maraver J, Cordero MD, Oropesa-Avila M, Vega AF, de la Mata M, Pavon AD, et al. Clinical applications of coenzyme Q10. Front Biosci (Landmark Ed). 2014;19(4):619-33.
Huang Y, Cao D, Chen Z, Chen B, Li J, Guo J, et al. Red and processed meat consumption and cancer outcomes: Umbrella review. Food Chem. 2021;356:129697.
Ikushima S, Ono R, Fukuda K, Sakayori M, Awano N, Kondo K. Trousseau's syndrome: cancer-associated thrombosis. Jpn J Clin Oncol. 2016;46(3):204-8.
Khammissa RAG, Fourie J, Motswaledi MH, Ballyram R, Lemmer J, Feller L. The Biological Activities of Vitamin D and Its Receptor in Relation to Calcium and Bone Homeostasis, Cancer, Immune and Cardiovascular Systems, Skin Biology, and Oral Health. Biomed Res Int. 2018;2018:9276380.
Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Physician. 2007;75(5):671-8.
Klimant E, Wright H, Rubin D, Seely D, Markman M. Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach. Curr Oncol. 2018;25(2):139-48.
Koleini N, Shapiro JS, Geier J, Ardehali H. Ironing out mechanisms of iron homeostasis and disorders of iron deficiency. J Clin Invest. 2021;131(11).
Locatelli F, Del Vecchio L. Hypoxia-Inducible Factor-Prolyl Hydroxyl Domain Inhibitors: From Theoretical Superiority to Clinical Noninferiority Compared with Current ESAs? J Am Soc Nephrol. 2022;33(11):1966-79.
Lucenteforte E, Garavello W, Bosetti C, La Vecchia C. Dietary factors and oral and pharyngeal cancer risk. Oral Oncol. 2009;45(6):461-7.
Meurman JH. Infectious and dietary risk factors of oral cancer. Oral Oncol. 2010;46(6):411-3.
Münstedt K, Männle H. Using Bee Products for the Prevention and Treatment of Oral Mucositis Induced by Cancer Treatment. Molecules. 2019;24(17).
Myint ZW, Oo TH, Thein KZ, Tun AM, Saeed H. Copper deficiency anemia: review article. Ann Hematol. 2018;97(9):1527-34.
Natale P, Palmer SC, Jaure A, Hodson EM, Ruospo M, Cooper TE, et al. Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. 2022;8(8):Cd013751.
Natalucci V, Virgili E, Calcagnoli F, Valli G, Agostini D, Zeppa SD, et al. Cancer Related Anemia: An Integrated Multitarget Approach and Lifestyle Interventions. Nutrients. 2021;13(2).
Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr. 2003;22(1):18-35.
Palmer S. Diet, nutrition, and cancer. Prog Food Nutr Sci. 1985;9(3-4):283-341.
Pelucchi C, Talamini R, Negri E, Levi F, Conti E, Franceschi S, et al. Folate intake and risk of oral and pharyngeal cancer. Ann Oncol. 2003;14(11):1677-81.
Powers JM, Buchanan GR. Disorders of Iron Metabolism: New Diagnostic and Treatment Approaches to Iron Deficiency. Hematol Oncol Clin North Am. 2019;33(3):393-408.
Richter P, Faroon O, Pappas RS. Cadmium and Cadmium/Zinc Ratios and Tobacco-Related Morbidities. Int J Environ Res Public Health. 2017;14(10).
Rolfe HM. A review of nicotinamide: treatment of skin diseases and potential side effects. J Cosmet Dermatol. 2014;13(4):324-8.
Searle T, Ali FR, Al-Niaimi F. Zinc in dermatology. J Dermatolog Treat. 2022;33(5):2455-8.
Shanbhag VC, Gudekar N, Jasmer K, Papageorgiou C, Singh K, Petris MJ. Copper metabolism as a unique vulnerability in cancer. Biochim Biophys Acta Mol Cell Res. 2021;1868(2):118893.
Shepshelovich D, Rozen-Zvi B, Avni T, Gafter U, Gafter-Gvili A. Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: An Updated Systematic Review and Meta-analysis. Am J Kidney Dis. 2016;68(5):677-90.
Taghavi N, Yazdi I. Type of food and risk of oral cancer. Arch Iran Med. 2007;10(2):227-32.
Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006;54(5):824-44.
van Es N, Büller HR. Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations. Hematology Am Soc Hematol Educ Program. 2015;2015:125-31.
Vedovati MC, Germini F, Agnelli G, Becattini C. Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis. Chest. 2015;147(2):475-83.
Yueying C, Yu Fan W, Jun S. Anemia and iron deficiency in Crohn's disease. Expert Rev Gastroenterol Hepatol. 2020;14(3):155-62.
Ali MM, Vaidya V. Vitamin D and cancer. J Cancer Res Ther. 2007;3(4):225-30.
Barysch MJ, Hofbauer GF, Dummer R. Vitamin D, ultraviolet exposure, and skin cancer in the elderly. Gerontology. 2010;56(4):410-3.
Bennett SL, Khachemoune A. Dispelling myths about sunscreen. J Dermatolog Treat. 2022;33(2):666-70.
Bens G. Sunscreens. Adv Exp Med Biol. 2014;810:429-63.
Bikle DD. Vitamin D and skin cancer. J Nutr. 2004;134(12 Suppl):3472s-8s.
Bikle DD, Oda Y, Tu CL, Jiang Y. Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer. J Steroid Biochem Mol Biol. 2015;148:47-51.
Breaker K, Naam M, La Rosa FG, Flaig IP, Flaig TW. Skin cancer associated with the use of sorafenib and sunitinib for renal cell carcinoma. Dermatol Surg. 2013;39(7):981-7.
Burns EM, Elmets CA, Yusuf N. Vitamin D and skin cancer. Photochem Photobiol. 2015;91(1):201-9.
Caini S, Boniol M, Tosti G, Magi S, Medri M, Stanganelli I, et al. Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis. Eur J Cancer. 2014;50(15):2649-58.
Carlberg C. Nutrigenomics of Vitamin D. Nutrients. 2019;11(3).
Chen AC, Damian DL. Nicotinamide and the skin. Australas J Dermatol. 2014;55(3):169-75.
Damian DL. Nicotinamide for skin cancer chemoprevention. Australas J Dermatol. 2017;58(3):174-80.
Gandini S, Raimondi S, Gnagnarella P, Doré JF, Maisonneuve P, Testori A. Vitamin D and skin cancer: a meta-analysis. Eur J Cancer. 2009;45(4):634-41.
Giacalone S, Spigariolo CB, Bortoluzzi P, Nazzaro G. Oral nicotinamide: The role in skin cancer chemoprevention. Dermatol Ther. 2021;34(3):e14892.
Glossmann H. Vitamin D, UV, and skin cancer in the elderly: to expose or not to expose? Gerontology. 2011;57(4):350-3.
Godic A, Poljšak B, Adamic M, Dahmane R. The role of antioxidants in skin cancer prevention and treatment. Oxid Med Cell Longev. 2014;2014:860479.
Grant WB. Solar ultraviolet irradiance and cancer incidence and mortality. Adv Exp Med Biol. 2014;810:52-68.
Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80(6 Suppl):1678s-88s.
Holick MF. Sunlight, ultraviolet radiation, vitamin D and skin cancer: how much sunlight do we need? Adv Exp Med Biol. 2014;810:1-16.
Holick MF. Sunlight, UV Radiation, Vitamin D, and Skin Cancer: How Much Sunlight Do We Need? Adv Exp Med Biol. 2020;1268:19-36.
Huang HY, Caballero B, Chang S, Alberg A, Semba R, Schneyer C, et al. Multivitamin/mineral supplements and prevention of chronic disease. Evid Rep Technol Assess (Full Rep). 2006(139):1-117.
Madaan P, Sikka P, Malik DS. Cosmeceutical Aptitudes of Niacinamide: A Review. Recent Adv Antiinfect Drug Discov. 2021;16(3):196-208.
Martin-Gorgojo A, Gilaberte Y, Nagore E. Vitamin D and Skin Cancer: An Epidemiological, Patient-Centered Update and Review. Nutrients. 2021;13(12).
Matthews NH, Fitch K, Li WQ, Morris JS, Christiani DC, Qureshi AA, et al. Exposure to Trace Elements and Risk of Skin Cancer: A Systematic Review of Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2019;28(1):3-21.
Minocha R, Damian DL, Halliday GM. Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide? Photodermatol Photoimmunol Photomed. 2018;34(1):5-12.
Nakano T, Chiang KC, Chen CC, Chen PJ, Lai CY, Hsu LW, et al. Sunlight Exposure and Phototherapy: Perspectives for Healthy Aging in an Era of COVID-19. Int J Environ Res Public Health. 2021;18(20).
Nemer KM, Council ML. Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer. Dermatol Clin. 2019;37(3):287-95.
Passeron T, Bouillon R, Callender V, Cestari T, Diepgen TL, Green AC, et al. Sunscreen photoprotection and vitamin D status. Br J Dermatol. 2019;181(5):916-31.
Pawlowska E, Wysokinski D, Blasiak J. Nucleotide Excision Repair and Vitamin D--Relevance for Skin Cancer Therapy. Int J Mol Sci. 2016;17(4):372.
Piotrowska A, Wierzbicka J, Żmijewski MA. Vitamin D in the skin physiology and pathology. Acta Biochim Pol. 2016;63(1):17-29.
Reichrath J. Skin cancer prevention and UV-protection: how to avoid vitamin D-deficiency? Br J Dermatol. 2009;161 Suppl 3:54-60.
Reichrath J. Solar ultraviolet radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs): an update. Adv Exp Med Biol. 2014;810:253-71.
Reichrath J, Nürnberg B. Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs). Adv Exp Med Biol. 2008;624:203-14.
Reichrath J, Reichrath S, Vogt T, Römer K. Crosstalk Between Vitamin D and p53 Signaling in Cancer: An Update. Adv Exp Med Biol. 2020;1268:307-18.
Reichrath J, Saternus R, Vogt T. Endocrine actions of vitamin D in skin: Relevance for photocarcinogenesis of non-melanoma skin cancer, and beyond. Mol Cell Endocrinol. 2017;453:96-102.
Sample A, He YY. Mechanisms and prevention of UV-induced melanoma. Photodermatol Photoimmunol Photomed. 2018;34(1):13-24.
Saternus R, Vogt T, Reichrath J. Update: Solar UV Radiation, Vitamin D, and Skin Cancer Surveillance in Organ Transplant Recipients (OTRs). Adv Exp Med Biol. 2020;1268:335-53.
Schulman JM, Fisher DE. Indoor ultraviolet tanning and skin cancer: health risks and opportunities. Curr Opin Oncol. 2009;21(2):144-9.
Sherwani MA, Tufail S, Muzaffar AF, Yusuf N. The skin microbiome and immune system: Potential target for chemoprevention? Photodermatol Photoimmunol Photomed. 2018;34(1):25-34.
Slominski AT, Zmijewski MA, Semak I, Zbytek B, Pisarchik A, Li W, et al. Cytochromes p450 and skin cancer: role of local endocrine pathways. Anticancer Agents Med Chem. 2014;14(1):77-96.
Stoj V, Shahriari N, Shao K, Feng H. Nutrition and nonmelanoma skin cancers. Clin Dermatol. 2022;40(2):173-85.
Thompson KG, Kim N. Dietary supplements in dermatology: A review of the evidence for zinc, biotin, vitamin D, nicotinamide, and Polypodium. J Am Acad Dermatol. 2021;84(4):1042-50.
Tuckey RC, Cheng CYS, Slominski AT. The serum vitamin D metabolome: What we know and what is still to discover. J Steroid Biochem Mol Biol. 2019;186:4-21.
Uliasz A, Spencer JM. Chemoprevention of skin cancer and photoaging. Clin Dermatol. 2004;22(3):178-82.
Vinceti M, Filippini T, Cilloni S, Crespi CM. The Epidemiology of Selenium and Human Cancer. Adv Cancer Res. 2017;136:1-48.
Vinceti M, Filippini T, Del Giovane C, Dennert G, Zwahlen M, Brinkman M, et al. Selenium for preventing cancer. Cochrane Database Syst Rev. 2018;1(1):Cd005195.
Vishlaghi N, Lisse TS. Exploring vitamin D signalling within skin cancer. Clin Endocrinol (Oxf). 2020;92(4):273-81.
